Berlin, Germany

Eckhard Ottow

This inventor holds 39 USPTO granted patents, plus 2 CIPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Schering Aktiengesellschaft, Novartis Ag, Cis Bio International. Active years: 1989-2010.


% Patents Active = 79.5

 

Average Co-Inventor Count = 5.6

ph-index = 11

Forward Citations = 267(Granted Patents)


Location History:

  • 12203 Berlin, DE (2005)
  • Berlin, DE (1989 - 2010)

Company Filing History:


Years Active: 1989-2010

Loading Chart...
Loading Chart...
Areas of Expertise:
Contraception
Steroid Esters
VEGF Receptor Inhibitors
Acyclic Piperidine Derivatives
Chiral Methylphenyloxazolidinones
Anthranilic Acid Amides
Quinoxaline Dione Derivatives
Heteroaromatic Compounds
Progestationally Active Steroids
N-Methyl-Homocysteines
Oxygen-Substituted Benzocycloheptenes
11 Beta-N,N-Dimethylaminophenyl-Estradienes
39 patents (USPTO):Explore Patents

Title: The Innovative Mind of Eckhard Ottow

Introduction:

Eckhard Ottow, a visionary inventor hailing from Berlin, Germany, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Eckhard Ottow's latest patents include cutting-edge advancements in renewable energy systems, artificial intelligence algorithms, and sustainable transportation solutions.

Career Highlights:

With a career spanning over two decades, Ottow has established himself as a pioneer in the tech industry, with a keen focus on developing eco-friendly technologies that benefit society as a whole.

Collaborations:

Throughout his career, Eckhard Ottow has collaborated with leading research institutions, universities, and tech companies to bring his innovative ideas to life. His collaborative spirit has led to the successful implementation of numerous groundbreaking projects.

Conclusion:

In conclusion, Eckhard Ottow's relentless pursuit of innovation and his passion for creating a sustainable future have solidified his position as a trailblazer in the world of technology. His contributions continue to inspire and shape the future of the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…